Mark S Slaughter

Summary

Affiliation: University of Louisville
Country: USA

Publications

  1. ncbi Increase in circadian variation after continuous-flow ventricular assist device implantation
    Mark S Slaughter
    Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Louisville, Louisville, KY 40202, USA
    J Heart Lung Transplant 29:695-7. 2010
  2. ncbi Transcutaneous energy transmission for mechanical circulatory support systems: history, current status, and future prospects
    Mark S Slaughter
    Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, Kentucky 40202, USA
    J Card Surg 25:484-9. 2010
  3. ncbi Transapical miniaturized ventricular assist device: design and initial testing
    Mark S Slaughter
    Department of Surgery, Cardiovascular Innovation Institute, University of Louisville, Louisville, KY 40202, USA
    J Thorac Cardiovasc Surg 142:668-74. 2011
  4. ncbi Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device
    Mark S Slaughter
    Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Louisville, Louisville, KY 40202, USA
    Int J Artif Organs 34:461-8. 2011
  5. ncbi Reducing emboli in cardiac surgery: does it make a difference?
    Mark S Slaughter
    Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, IL, USA
    Artif Organs 32:880-4. 2008
  6. ncbi The total artificial heart
    A Meyer
    Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, KY, USA
    Panminerva Med 53:141-54. 2011
  7. ncbi Intraoperative evaluation of the HeartMate II flow estimator
    Mark S Slaughter
    Division of Cardiothoracic Surgery, Cardiovascular Innovation Institute, University of Louisville, Kentucky, USA
    J Heart Lung Transplant 28:39-43. 2009
  8. ncbi Temporal changes in hospital costs for left ventricular assist device implantation
    Mark S Slaughter
    Division of Cardiothoracic Surgery, University of Louisville, KY 40202, USA
    J Card Surg 26:535-41. 2011
  9. ncbi Destination therapy with left ventricular assist devices: patient selection and outcomes
    Mark S Slaughter
    Division of Thoracic and Cardiovascular Surgery, University of Louisville, 201 Abraham Flexner Way, Louisville, KY 40202, USA
    Curr Opin Cardiol 26:232-6. 2011
  10. ncbi Advanced heart failure treated with continuous-flow left ventricular assist device
    Mark S Slaughter
    Advocate Christ Medical Center, Oak Lawn, IL, USA
    N Engl J Med 361:2241-51. 2009

Collaborators

Detail Information

Publications49

  1. ncbi Increase in circadian variation after continuous-flow ventricular assist device implantation
    Mark S Slaughter
    Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Louisville, Louisville, KY 40202, USA
    J Heart Lung Transplant 29:695-7. 2010
    ..The return of the circadian rhythm has implications for cardiac recovery, and the observation indicates that the continuous-flow LVAD has an intrinsic automatic response to physiologic demands...
  2. ncbi Transcutaneous energy transmission for mechanical circulatory support systems: history, current status, and future prospects
    Mark S Slaughter
    Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, Kentucky 40202, USA
    J Card Surg 25:484-9. 2010
    ..A totally implantable LVAD with an incorporated TETS for destination therapy could become an important advance in the treatment of end-stage heart failure...
  3. ncbi Transapical miniaturized ventricular assist device: design and initial testing
    Mark S Slaughter
    Department of Surgery, Cardiovascular Innovation Institute, University of Louisville, Louisville, KY 40202, USA
    J Thorac Cardiovasc Surg 142:668-74. 2011
    ..We evaluated a new miniaturized left ventricular assist device that requires minimal surgery for implantation, potentially allowing implantation in earlier stage heart failure...
  4. ncbi Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device
    Mark S Slaughter
    Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Louisville, Louisville, KY 40202, USA
    Int J Artif Organs 34:461-8. 2011
    ..In this study, markers of platelet activation were investigated in HF patients supported by a HeartMate II left ventricular assist device (LVAD)...
  5. ncbi Reducing emboli in cardiac surgery: does it make a difference?
    Mark S Slaughter
    Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, IL, USA
    Artif Organs 32:880-4. 2008
    ....
  6. ncbi The total artificial heart
    A Meyer
    Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, KY, USA
    Panminerva Med 53:141-54. 2011
    ..In this review article, a brief history on the evolution of TAH devices, their current use and emerging use of evolving continuous flow VAD technology as chronic biventricular and TAH device systems are presented...
  7. ncbi Intraoperative evaluation of the HeartMate II flow estimator
    Mark S Slaughter
    Division of Cardiothoracic Surgery, Cardiovascular Innovation Institute, University of Louisville, Kentucky, USA
    J Heart Lung Transplant 28:39-43. 2009
    ..This study evaluated the accuracy of HeartMate II flow estimation at the time of implantation...
  8. ncbi Temporal changes in hospital costs for left ventricular assist device implantation
    Mark S Slaughter
    Division of Cardiothoracic Surgery, University of Louisville, KY 40202, USA
    J Card Surg 26:535-41. 2011
    ..The current study examines the hospitalization costs associated with treatment of New York Heart Failure Class IV patients when implanted with a CF LVAD and compares them to previously reported costs of a PF LVAD in the same population...
  9. ncbi Destination therapy with left ventricular assist devices: patient selection and outcomes
    Mark S Slaughter
    Division of Thoracic and Cardiovascular Surgery, University of Louisville, 201 Abraham Flexner Way, Louisville, KY 40202, USA
    Curr Opin Cardiol 26:232-6. 2011
    ..With the advent of continuous-flow LVADs, safe and effective long-term circulatory support is available for properly identified candidates...
  10. ncbi Advanced heart failure treated with continuous-flow left ventricular assist device
    Mark S Slaughter
    Advocate Christ Medical Center, Oak Lawn, IL, USA
    N Engl J Med 361:2241-51. 2009
    ..New continuous-flow devices are smaller and may be more durable than the pulsatile-flow devices...
  11. ncbi Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy
    Mark S Slaughter
    Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, Kentucky 40202, USA
    J Heart Lung Transplant 29:616-24. 2010
    ..We retrospectively evaluated the effects of heparin use on thromboembolic and bleeding complications after implantation of the HeartMate II left ventricular assist device (LVAD)...
  12. ncbi Implantation of the HeartWare left ventricular assist device
    Mark S Slaughter
    Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, Kentucky, USA
    Semin Thorac Cardiovasc Surg 23:245-7. 2011
    ..The HeartWare HVAD is a new continuous flow LVAD, currently in trials, that is designed to be implanted and contained completely within the pericardial space...
  13. ncbi Evaluation of new Forcefield technology: reducing platelet adhesion and cell coverage of pyrolytic carbon surfaces
    Mark S Slaughter
    Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Louisville, Louisville, KY, USA
    J Thorac Cardiovasc Surg 142:921-5. 2011
    ..A modulated low-voltage current is directly applied to pyrolytic carbon surfaces to stimulate adherence of a layer of charged proteins from circulating blood components that is resistive to platelet deposition...
  14. ncbi Hematologic effects of continuous flow left ventricular assist devices
    Mark S Slaughter
    Division of Thoracic and Cardiovascular Surgery, University of Louisville, 201 Abraham Flexner Way, Louisville, KY 40202, USA
    J Cardiovasc Transl Res 3:618-24. 2010
    ..Because bleeding causes significant morbidity for this population, more effective treatment strategies need to be developed...
  15. ncbi Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy
    Mark S Slaughter
    Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, Kentucky 40202, USA
    J Card Surg 25:490-4. 2010
    ..Current clinical evidence indicates that end-organ perfusion and function can be well maintained for extended durations of support with a CF-LVAD...
  16. ncbi Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device
    Mark S Slaughter
    Cardiac Surgery Research and Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
    Tex Heart Inst J 35:245-9. 2008
    ..They also suggest that modifications made to the HeartMate LVAD since the REMATCH trial have resulted in fewer complications, and that better patient selection and supportive care have improved outcomes...
  17. ncbi Human, bovine and porcine systematic vascular input impedances are not equivalent: implications for device testing and xenotransplantation in heart failure
    Steven C Koenig
    Cardiovascular Innovation Institute, Department of Bioengineering and Surgery, University of Louisville, Louisville, Kentucky 502 852 1795, USA
    J Heart Lung Transplant 27:1340-7. 2008
    ..Systemic aortic input impedance (Z(ART)) is an important physiologic determinant of left ventricular (LV) performance. We tested the hypothesis that Z(ART) is lower in bovine and porcine than in humans with normal or failing hearts...
  18. ncbi Acute hemodynamic efficacy of a 32-ml subcutaneous counterpulsation device in a calf model of diminished cardiac function
    Steven C Koenig
    Department of Bioengineering, Cardiovascular Innovation Institute, University of Louisville, Louisville, Kentucky 40202, USA
    ASAIO J 54:578-84. 2008
    ..The CPD provides hemodynamic efficacy equivalent to an IABP and may become a therapeutic option for patients who may benefit from prolonged counterpulsation...
  19. ncbi HeartWare miniature axial-flow ventricular assist device: design and initial feasibility test
    Mark S Slaughter
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    Tex Heart Inst J 36:12-6. 2009
    ..Further in vivo testing is planned. Herein, we discuss the unique design of the HeartWare miniature ventricular assist device, our feasibility study of its performance, and the possibilities for its use in human beings...
  20. ncbi Heart transplant vs left ventricular assist device in heart transplant-eligible patients
    Matthew L Williams
    Division of Thoracic and Cardiovascular Surgery, University of Louisville, and Jewish Hospital Transplant Center, Louisville, Kentucky 40202, USA
    Ann Thorac Surg 91:1330-3; discussion 1333-4. 2011
    ..We evaluated 1-year outcome and effectiveness of LVAD vs heart transplantation...
  21. ncbi Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device
    Adam R Travis
    Cardiovascular Innovation Institute, University of Louisville, Louisville, KY 40202, USA
    J Thorac Cardiovasc Surg 133:517-24. 2007
    ....
  22. ncbi Managing mechanical valves with reduced anticoagulation
    Mark S Slaughter
    Advocate Christ Medical Center, 4440 West 95th Street, Oak Lawn, IL 60453, USA
    Expert Rev Cardiovasc Ther 5:1073-85. 2007
    ..The current trend is more frequent use of bioprosthetic valves; however, this trend may again reverse as therapy for mechanical valves is refined...
  23. ncbi Hemodynamic responses to continuous versus pulsatile mechanical unloading of the failing left ventricle
    Carlo R Bartoli
    University of Louisville School of Medicine, Kentucky, USA
    ASAIO J 56:410-6. 2010
    ..These findings may have important implications for chronic LVAD therapy...
  24. ncbi Destination therapy: safety and feasibility of national and international travel
    Laura A Coyle
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    ASAIO J 54:172-6. 2008
    ..All patients returned home safely for routine follow-up. Long-distance travel is possible for DT patients. Anticipating potential problems and careful planning is necessary for safe national and international travel...
  25. ncbi A novel subcutaneous counterpulsation device: acute hemodynamic efficacy during pharmacologically induced hypertension, hypotension, and heart failure
    Carlo R Bartoli
    MD PhD Program, University of Louisville School of Medicine, Louisville, KY, USA
    Artif Organs 34:537-45. 2010
    ..A novel 32-mL CPD connected to a peripheral artery produced equivalent or greater hemodynamic benefits than a standard 40-mL IABP during pharmacologically induced hypertension, hypotension, and heart failure conditions...
  26. ncbi Left ventricular assist device weaning: hemodynamic response and relationship to stroke volume and rate reduction protocols
    Mark S Slaughter
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    ASAIO J 52:228-33. 2006
    ..The long-term effects of steady-state and transient LV mechanical reloading on myocardial structure and function toward achieving sustained myocardial recovery warrant further investigation...
  27. ncbi Peripheral cardiopulmonary bypass with modified assisted venous drainage and transthoracic aortic crossclamp: optimal management for robotic mitral valve repair
    Michael A Sobieski
    Division of Cardiac Surgery, Christ Hospital and Medical Center, Oak Lawn, IL, USA
    Perfusion 18:307-11. 2003
    ..This approach may be applied to other forms of minimally invasive cardiac surgery that requires CPB...
  28. ncbi Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator use
    Michael A Sobieski
    Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, IL, USA
    Perfusion 20:31-7. 2005
    ..Evaluate the feasibility and clinical significance of crystalloid prime reduction during the initiation of cardiopulmonary bypass (CPB) using a modified bridge on the cardioplegia delivery system...
  29. ncbi Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
    Mark S Slaughter
    University of Louisville, Louisville, Kentucky, USA
    J Heart Lung Transplant 29:S1-39. 2010
    ..Ongoing trials with other continuous-flow devices may produce additional information in the future for improving clinical management of patients with these devices...
  30. ncbi Destination therapy: one-year outcomes in patients with a body mass index greater than 30
    Laura A Coyle
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL, USA
    Artif Organs 34:93-7. 2010
    ..2 vs. 1.6), and survival (63% vs. 65%). Our initial results demonstrate that morbidly obese patients with end-stage heart failure with a contraindication for transplant may successfully undergo implantation of an LVAD for DT...
  31. ncbi Utilization of acoustic signatures to identify HeartMate XVE device end-of-life
    Mark S Slaughter
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
    J Heart Lung Transplant 26:579-83. 2007
    ..In this study we assess a non-invasive technique using acoustic signals generated from the HeartMate XVE LVAD to potentially identify impending device end-of-life issues...
  32. ncbi Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial
    Roberto Bolli
    Divisions of Cardiovascular Medicine, University of Louisville, Louisville, KY 40202, USA
    Lancet 378:1847-57. 2011
    ..We undertook a phase 1 trial (Stem Cell Infusion in Patients with Ischemic cardiOmyopathy [SCIPIO]) of autologous CSCs for the treatment of heart failure resulting from ischaemic heart disease...
  33. ncbi Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device
    Mark S Slaughter
    Advocate Christ Medical Center, Oak Lawn, Ill 60453, USA
    J Thorac Cardiovasc Surg 133:1573-80. 2007
    ..3 m(2). Results of the multicenter clinical trial are reviewed...
  34. ncbi Minimally invasive mitral valve repair using the da Vinci robotic system
    Antone J Tatooles
    Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    Ann Thorac Surg 77:1978-82; discussion 1982-4. 2004
    ..CONCLUSIONS: Mitral valve repair can be successfully performed with the da Vinci robotic system. Long-term follow-up is needed to determine the durability of the repair compared with a standard sternotomy approach...
  35. ncbi Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy
    Soon J Park
    Division of Cardiac Surgery, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Circ Heart Fail 5:241-8. 2012
    ..The primary hypothesis of the current study is that trial patients enrolled after the initial data cohort would have better clinical outcomes...
  36. ncbi Blood trauma testing for mechanical circulatory support devices
    Guruprasad A Giridharan
    Department of Bioengineering, University of Louisville, Louisville, KY, USA
    Biomed Instrum Technol 45:334-9. 2011
    ..Standardization of hemolysis testing procedures and transparency of results may enable better blood trauma characterization of MCS devices to facilitate the FDA 510(k) and PMA submission processes and improve clinical outcomes...
  37. ncbi Embol-X intra-aortic filtration system: capturing particulate emboli in the cardiac surgery patient
    Michael A Sobieski
    Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    J Extra Corpor Technol 37:222-6. 2005
    ..Clearly, the reduction of particulate matter by as much as 95% justifies its use in cardiac surgery patients identified with an increased pre-operative embolic risk...
  38. ncbi Improvement in early oxygen uptake kinetics with left ventricular assist device support
    Chad M Feldman
    Internal Medicine, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    ASAIO J 54:406-11. 2008
    ..7 seconds to 35.8 +/- 13.3 seconds (p = 0.046) with LVAD support. Improved oxygen kinetics suggests improved peripheral utilization of oxygen, and may offer an additional clinical parameter to predict the likelihood of sustained recovery...
  39. ncbi Reducing the effects of the systemic inflammatory response to cardiopulmonary bypass: can single dose steroids blunt systemic inflammatory response syndrome?
    Michael A Sobieski
    Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    ASAIO J 54:203-6. 2008
    ..Despite the significant reductions in IL-6 and PNE, there was no effect on clinical outcomes. Additional studies are needed to demonstrate a clinically significant effect on patient outcomes...
  40. ncbi Home discharge experience with the Thoratec TLC-II portable driver
    Mark S Slaughter
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    ASAIO J 53:132-5. 2007
    ..There were no readmissions for device malfunction, emergency battery utilization or back-up unit use. These results demonstrate that the Thoratec TLC-II portable driver is safe, reliable, and can be effectively managed at home...
  41. ncbi Fibrinolytic activation during long-term support with the HeartMate II left ventricular assist device
    Mark S Slaughter
    Cardiac Surgery Research, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
    ASAIO J 54:115-9. 2008
    ..Three nonfatal bleeding events but no thromboembolic events were observed. Fibrinolytic responses initially increase after LVAD implantation but then gradually normalize...
  42. ncbi Management of aortic insufficiency with continuous flow left ventricular assist devices: bioprosthetic valve replacement
    Chad M Feldman
    Advocate Christ Medical Center, Mechanical Assist Device Program, Oak Lawn, Illinois 60453, USA
    J Heart Lung Transplant 25:1410-2. 2006
    ..We report on two patients with bioprosthetic aortic valve replacement for aortic insufficiency at the time of HeartMate II LVAD insertion...
  43. ncbi Coronary artery fistula: 64-slice computed tomographic delineation and correlation with multiplane transesophageal echocardiography and surgical findings
    Jonathan K Joshi
    Radiology Medicine Surgery, University of Louisville, Louisville, KY, USA
    Echocardiography 29:E69-71. 2012
    ..Findings were ultimately confirmed at cardiac catheterization. Coronary steal was clinically diagnosed and she underwent surgical ligation and resection of the fistula and aneurysm. Her subsequent course was uncomplicated...
  44. ncbi Is female sex an independent risk factor for perioperative transfusion in coronary artery bypass graft surgery?
    Matthew L Williams
    Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, KY, USA
    J Am Coll Surg 212:362-6. 2011
    ..We evaluated female sex as an independent risk factor for red blood cell transfusion in CABG, while accounting for hematocrit...
  45. ncbi The Thoratec mobile computer: initial in-hospital and outpatient experience
    Michael A Sobieski
    Division of Cardiac Surgery, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    ASAIO J 50:373-5. 2004
    ..Data were successfully obtained in all cases. Documentation of programmed settings and driver operation was achieved without difficulty...
  46. ncbi Antegrade versus Retrograde Cerebral Protection in Repair of Acute Ascending Aortic Dissection
    Matthew L Williams
    Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, Kentucky, USA
    Am Surg 78:349-51. 2012
    ..514 and 0.956, respectively). No compelling evidence for an advantage to either antegrade or retrograde cerebral perfusion was detected. Further study with a focus on neurologic outcomes is warranted...
  47. ncbi Destination therapy: the future is arriving
    Mark S Slaughter
    Department of Cardiothoracic Surgery, Mechanical Assist Device Program, Advocate Christ Medical Center, 4400 West 95th Street, Oak Lawn, IL 60453, USA
    Congest Heart Fail 11:155-6. 2005
  48. ncbi Percutaneous endoscopic gastrostomy tube in a patient with a left ventricular assist device
    Mark S Slaughter
    Division Cardiac Surgery, Mechanical Assist Device Program, Advocate Christ Medical Center, 4400 W. 95th Street, Suite 205, Oak Lawn, IL 60453, USA
    ASAIO J 49:611-2. 2003
    ..We believe that PEG placement should be cpnsidered in patients with an LVAD with swallowing difficulties or who are debilitated are not meeting their caloric requirements...
  49. ncbi Acute myocardial infarction complicated by cardiogenic shock: role of mechanical circulatory support
    Sanjeev Aggarwal
    University of Louisville, Cardiovascular Innovation Institute, Division of Thoracic and Cardiovascular Surgery, Louisville, KY 40202, USA
    Expert Rev Cardiovasc Ther 6:1223-35. 2008
    ..However, access to revascularization and VAD support, including percutaneous VADs, is currently limited and must improve to more effectively treat AMI-CS patients...